Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Dec 26, 2024

BUY
$0.18 - $0.32 $47 - $84
263 New
263 $0
Q1 2024

May 10, 2024

BUY
$0.18 - $0.32 $0 - $1
5 Added 1.94%
263 $0
Q4 2023

Dec 26, 2024

BUY
$0.16 - $0.44 $41 - $113
258 New
258 $0
Q4 2023

Feb 12, 2024

SELL
$0.16 - $0.44 $4,672 - $12,850
-29,205 Reduced 99.12%
258 $0
Q3 2023

Nov 14, 2023

BUY
$0.34 - $0.65 $1,543 - $2,950
4,539 Added 18.21%
29,463 $12,000
Q2 2023

Aug 11, 2023

SELL
$0.37 - $1.88 $41,061 - $208,638
-110,978 Reduced 81.66%
24,924 $9,000
Q1 2023

May 18, 2023

BUY
$1.75 - $2.7 $227,377 - $350,811
129,930 Added 2175.65%
135,902 $247,000
Q1 2023

May 11, 2023

SELL
$1.75 - $2.7 $540,079 - $833,265
-308,617 Reduced 98.1%
5,972 $10,000
Q4 2022

Feb 13, 2023

BUY
$1.72 - $4.1 $83,621 - $199,329
48,617 Added 18.28%
314,589 $651,000
Q3 2022

Nov 14, 2022

BUY
$2.92 - $4.88 $608,399 - $1.02 Million
208,356 Added 361.63%
265,972 $801,000
Q2 2022

Aug 11, 2022

BUY
$3.2 - $7.0 $151,526 - $331,464
47,352 Added 461.34%
57,616 $184,000
Q1 2022

May 11, 2022

BUY
$6.45 - $14.67 $30,327 - $68,978
4,702 Added 84.54%
10,264 $66,000
Q4 2021

Feb 10, 2022

BUY
$8.92 - $15.66 $49,613 - $87,100
5,562 New
5,562 $75,000

Others Institutions Holding HLTH

About Cue Health Inc.


  • Ticker HLTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 148,152,992
  • Description
  • Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of ...
More about HLTH
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.